Stockreport

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy [Seeking Alpha]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF Legend Biotech continues to invest in R&D to expand the number of indications that Carvykti can treat, with seven clinical studies now in progress. Legend's Carvykti [Read more]